Skip to search formSkip to main contentSkip to account menu

Epoprostenol Sodium

Known as: Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, Sodium salt, (5Z,9alpha,11alpha,13E,15S)-, Sodium(Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate, Epoprostenol Sodium [Chemical/Ingredient] 
The sodium salt form of epoprostenol, a synthetic prostacyclin, a member of the family of prostaglandins, with vasodilatory and anticoagulant… 
National Institutes of Health

Related topics

Related topics

18 relations
Arterial Vasodilation [PE]ArteriosclerosisCongestive heart failureDecreased Blood Pressure [PE]

Narrower (2)

FlolanVeletri

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Early outcomes after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension in the era of epoprostenol sodium
Objectives: Pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH) is technically demanding. We… 
2016
2016
5.01.522 Advanced Therapies for Pharmacological Treatment of Pulmonary Arterial Hypertension
  • 2016
  • Corpus ID: 6820140
The following therapies may be considered medically necessary for the treatment of pulmonary arterial hypertension (PAH/ WHO… 
2008
2008
Treprostinil en el tratamiento de la hipertensión arterial pulmonar
La prostaciclina y sus analogos constituyen la piedra angular del tratamiento de la hipertension arterial pulmonar, ejerciendo… 
2007
2007
PJ-832 Epoprostenol Improves the Vasoreactivity to Oxygen in Patients with PAH(Pulmonary circulation-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
2007
2007
Profile: Jean-Paul Clozel
When Merck KGaA purchased Geneva-based Serono in September, Actelion became Switzerland's largest biotech. 
2003
2003
特発性門脈閉塞症の術後に発症した門脈肺高血圧症に対する Epoprostenol 持続静注療法の治療経験
Review
2002
Review
2002
Gateways to Clinical Trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
1996
1996
Epoprostenol for primary pulmonary hypertension.
Epoprostenol sodium (Flolan-Glaxo Wellcome), also known as prostacyclin, has been approved by the US Food and Drug Administration… 
1986
1986
Epoprostenol sodium (prostacyclin) infusion in acute myocardial infarction.
Epoprostenol (prostacyclin) is a potent inhibitor of platelet aggregation and causes relaxation of vascular smooth muscle. These… 
1985
1985
Prostacyclin in severe peripheral vascular disease.
Prostacyclin (prostaglandin I2, epoprostenol sodium) arrested the progress of gangrene in the feet of a 6 year old boy with…